On August 1, 2025, a UK Court of Appeal upheld the validity of Moderna’s European Patent No. 3,590,949 (“EP’949”) in a dispute with Pfizer and BioNTech. The decision affirmed a July 2024 UK High Court ruling finding that...more
8/15/2025
/ Appeals ,
Coronavirus/COVID-19 ,
Inter Partes Review (IPR) Proceeding ,
Moderna Inc. ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Pfizer ,
Pharmaceutical Industry ,
Pharmaceutical Patents